Comparing the performance of dengue virus IgG and IgG-capture enzyme-linked immunosorbent assays in seroprevalence study
Abstract Background Dengue virus (DENV) is the leading cause of arboviral diseases in humans worldwide. Currently Dengvaxia, the first dengue vaccine licensed in 20 countries, was recommended for DENV seropositive individuals aged 9–45 years. Studying dengue seroprevalence can improve our understand...
Main Authors: | Jih-Jin Tsai, Ching-Yi Tsai, Ping-Chang Lin, Chun-Hong Chen, Wen-Yang Tsai, Yu-Ching Dai, Yen-Chia Lin, Celia Pedroso, Carlos Brites, Wei-Kung Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-023-08307-8 |
Similar Items
-
Seroprevalence of diphtheria toxoid IgG antibodies in the Malaysian population
by: Ahmad Faudzi Yusoff, et al.
Published: (2021-06-01) -
Significance of IgG optical density ratios (index value) in single reactive anti-Dengue virus IgG capture ELISA
by: Shiv Sekhar Chatterjee, et al.
Published: (2017-03-01) -
Seroprevalence of Hepatitis E Virus Antibodies (IgG) in the Community of Rawalpindi
by: Muhammad Awais Farooqi, et al.
Published: (2022-07-01) -
IgG/IgA pemphigus with differing regional presentations
by: Hok Fai Cheng, MBBS(HK), MRCP(UK), FHKAM(Medicine), et al.
Published: (2022-10-01) -
Mycoplasma pneumoniae: IgG and IgM antibody response in presence of different antigens. Evaluation of commercial tests
by: Mariella Tonella, et al.
Published: (2011-12-01)